PL02.04 Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: Primary Analysis of HARMONi-2

Caicun Zhou, Jingbo Chen, Linyu Wu, Long Wang, Biying Liu, Jiayi Yao, Huanzi Zhong, Jiarui Li, Y. Cheng, Yun Sun, Heng Ge, Qin Shi, Min Zhou, Zhiyu Han, Jingyuan Wang, Qing Bu, Yong Zhao, Jingbo Chen, Jin‐Ji Yang, M. Xia